[
  {
    "column": "S5r1",
    "description": "S5r1: For how many years have you practiced in this primary specialty, post-residency?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S5",
    "context": ""
  },
  {
    "column": "S6r1",
    "description": "S6r1: What percentage of your professional time is devoted to direct patient care / clinical practice as opposed to teaching, research or administration?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S6",
    "context": ""
  },
  {
    "column": "S7_Hr1c1",
    "description": "S7_Hr1c1: Acute myeloid leukemia (AML) - In the past 12 months, how many patients were presented with the following hematologic oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnose",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_H",
    "context": ""
  },
  {
    "column": "S7_Hr2c1",
    "description": "S7_Hr2c1: Acute lymphoblastic leukemia (ALL) - In the past 12 months, how many patients were presented with the following hematologic oncology conditions in your practice? Please consider all patients who came to your practice including those who were: di",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_H",
    "context": ""
  },
  {
    "column": "S7_Hr3c1",
    "description": "S7_Hr3c1: Prostate cancer - In the past 12 months, how many patients were presented with the following hematologic oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your pra",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_H",
    "context": ""
  },
  {
    "column": "S7_Hr4c1",
    "description": "S7_Hr4c1: Multiple myeloma - In the past 12 months, how many patients were presented with the following hematologic oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your pr",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_H",
    "context": ""
  },
  {
    "column": "S7_Hr5c1",
    "description": "S7_Hr5c1: Chronic lymphocytic leukemia (CLL) - In the past 12 months, how many patients were presented with the following hematologic oncology conditions in your practice? Please consider all patients who came to your practice including those who were: di",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_H",
    "context": ""
  },
  {
    "column": "S7_Hr6c1",
    "description": "S7_Hr6c1: Bladder cancer - In the past 12 months, how many patients were presented with the following hematologic oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your prac",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_H",
    "context": ""
  },
  {
    "column": "S7a_Hr1c1",
    "description": "S7a_Hr1c1: Acute myeloid leukemia (AML) - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following hematologic oncology conditions? For “actively managed” please refer to patients y",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_H",
    "context": ""
  },
  {
    "column": "S7a_Hr2c1",
    "description": "S7a_Hr2c1: Acute lymphoblastic leukemia (ALL) - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following hematologic oncology conditions? For “actively managed” please refer to pati",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_H",
    "context": ""
  },
  {
    "column": "S7a_Hr3c1",
    "description": "S7a_Hr3c1: Prostate cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following hematologic oncology conditions? For “actively managed” please refer to patients you have seen",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_H",
    "context": ""
  },
  {
    "column": "S7a_Hr4c1",
    "description": "S7a_Hr4c1: Multiple myeloma - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following hematologic oncology conditions? For “actively managed” please refer to patients you have seen",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_H",
    "context": ""
  },
  {
    "column": "S7a_Hr5c1",
    "description": "S7a_Hr5c1: Chronic lymphocytic leukemia (CLL) - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following hematologic oncology conditions? For “actively managed” please refer to pati",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_H",
    "context": ""
  },
  {
    "column": "S7a_Hr6c1",
    "description": "S7a_Hr6c1: Bladder cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following hematologic oncology conditions? For “actively managed” please refer to patients you have seen a",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_H",
    "context": ""
  },
  {
    "column": "S7_Or1c1",
    "description": "S7_Or1c1: Prostate cancer - In the past 12 months, how many patients were presented with the following oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and no",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_O",
    "context": ""
  },
  {
    "column": "S7_Or2c1",
    "description": "S7_Or2c1: Acute myeloid leukemia (AML) - In the past 12 months, how many patients were presented with the following oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your pr",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_O",
    "context": ""
  },
  {
    "column": "S7_Or3c1",
    "description": "S7_Or3c1: Acute lymphoblastic leukemia (ALL) - In the past 12 months, how many patients were presented with the following oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in y",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_O",
    "context": ""
  },
  {
    "column": "S7_Or4c1",
    "description": "S7_Or4c1: Breast cancer - In the past 12 months, how many patients were presented with the following oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and not",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_O",
    "context": ""
  },
  {
    "column": "S7_Or5c1",
    "description": "S7_Or5c1: Colorectal cancer - In the past 12 months, how many patients were presented with the following oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_O",
    "context": ""
  },
  {
    "column": "S7_Or6c1",
    "description": "S7_Or6c1: Bladder cancer - In the past 12 months, how many patients were presented with the following oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and not",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_O",
    "context": ""
  },
  {
    "column": "S7a_Or1c1",
    "description": "S7a_Or1c1: Prostate cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncology conditions? For “actively managed” please refer to patients you have seen at least onc",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_O",
    "context": ""
  },
  {
    "column": "S7a_Or2c1",
    "description": "S7a_Or2c1: Acute myeloid leukemia (AML) - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncology conditions? For “actively managed” please refer to patients you have seen",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_O",
    "context": ""
  },
  {
    "column": "S7a_Or3c1",
    "description": "S7a_Or3c1: Acute lymphoblastic leukemia (ALL) - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncology conditions? For “actively managed” please refer to patients you hav",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_O",
    "context": ""
  },
  {
    "column": "S7a_Or4c1",
    "description": "S7a_Or4c1: Breast cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncology conditions? For “actively managed” please refer to patients you have seen at least once",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_O",
    "context": ""
  },
  {
    "column": "S7a_Or5c1",
    "description": "S7a_Or5c1: Colorectal cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncology conditions? For “actively managed” please refer to patients you have seen at least o",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_O",
    "context": ""
  },
  {
    "column": "S7a_Or6c1",
    "description": "S7a_Or6c1: Bladder cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncology conditions? For “actively managed” please refer to patients you have seen at least once",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_O",
    "context": ""
  },
  {
    "column": "S7_Ur1c1",
    "description": "S7_Ur1c1: Prostate cancer - In the past 12 months, how many patients were presented with the following urology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and not",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_U",
    "context": ""
  },
  {
    "column": "S7_Ur2c1",
    "description": "S7_Ur2c1: Bladder cancer - In the past 12 months, how many patients were presented with the following urology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and not",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_U",
    "context": ""
  },
  {
    "column": "S7_Ur3c1",
    "description": "S7_Ur3c1: Testicular cancer - In the past 12 months, how many patients were presented with the following urology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and n",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_U",
    "context": ""
  },
  {
    "column": "S7_Ur4c1",
    "description": "S7_Ur4c1: Kidney cancer - In the past 12 months, how many patients were presented with the following urology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and not t",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_U",
    "context": ""
  },
  {
    "column": "S7a_Ur1c1",
    "description": "S7a_Ur1c1: Prostate cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following urology conditions? For “actively managed” please refer to patients you have seen at least once",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_U",
    "context": ""
  },
  {
    "column": "S7a_Ur2c1",
    "description": "S7a_Ur2c1: Bladder cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following urology conditions? For “actively managed” please refer to patients you have seen at least once",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_U",
    "context": ""
  },
  {
    "column": "S7a_Ur3c1",
    "description": "S7a_Ur3c1: Testicular cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following urology conditions? For “actively managed” please refer to patients you have seen at least on",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_U",
    "context": ""
  },
  {
    "column": "S7a_Ur4c1",
    "description": "S7a_Ur4c1: Kidney cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following urology conditions? For “actively managed” please refer to patients you have seen at least once i",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7a_U",
    "context": ""
  },
  {
    "column": "S7_Br1",
    "description": "S7_Br1: Of your [pipe: S7_B_Pipe] prostate cancer patients, how many were actively managed for non-curative prostate cancer in the past 12 months? Non-curative prostate cancer patients are those that have progressed after receiving definitive therapy (e.g",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_B",
    "context": ""
  },
  {
    "column": "S7_Cr1",
    "description": "S7_Cr1: Of your [pipe: S7_C_Pipe] bladder cancer patients actively managed in the past 12 months, how many were locally advanced or metastatic? Include patients you treat currently AND patients you referred to clinical trial in the last 12 months AND your",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S7_C",
    "context": ""
  },
  {
    "column": "S9r1c1",
    "description": "S9r1c1: General Practice - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S9",
    "context": ""
  },
  {
    "column": "S9r2c1",
    "description": "S9r2c1: Hematologist - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S9",
    "context": ""
  },
  {
    "column": "S9r3c1",
    "description": "S9r3c1: Hematologist-Oncologist - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S9",
    "context": ""
  },
  {
    "column": "S9r4c1",
    "description": "S9r4c1: Medical Oncologist - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S9",
    "context": ""
  },
  {
    "column": "S9r5c1",
    "description": "S9r5c1: Gastroenterologist - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S9",
    "context": ""
  },
  {
    "column": "S9r6c1",
    "description": "S9r6c1: Urologist - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S9",
    "context": ""
  },
  {
    "column": "S9r7c1",
    "description": "S9r7c1: Cardiologist - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S9",
    "context": ""
  },
  {
    "column": "S9r8c1",
    "description": "S9r8c1: $ {S8.r8.open} - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "S9",
    "context": ""
  },
  {
    "column": "Q1r1c1",
    "description": "Q1r1c1: Astellas - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Pl",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c2",
    "description": "Q1r1c2: Merck - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Pleas",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c3",
    "description": "Q1r1c3: Bristol-Myers Squibb (BMS) - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in th",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c4",
    "description": "Q1r1c4: Genentech / Roche - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c5",
    "description": "Q1r1c5: Pfizer - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Plea",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c6",
    "description": "Q1r1c6: Janssen / Johnson & Johnson - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in t",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c7",
    "description": "Q1r1c7: Bayer - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Pleas",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c8",
    "description": "Q1r1c8: Abbvie - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Plea",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c9",
    "description": "Q1r1c9: Sanofi - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Plea",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c10",
    "description": "Q1r1c10: Lilly - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Plea",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c11",
    "description": "Q1r1c11: Novartis - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?P",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c12",
    "description": "Q1r1c12: Daiichi-Sankyo - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 mo",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c13",
    "description": "Q1r1c13: Amgen - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Plea",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c14",
    "description": "Q1r1c14: Seattle Genetics - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c15",
    "description": "Q1r1c15: GSK - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Please",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c16",
    "description": "Q1r1c16: AstraZeneca - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 month",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q1r1c17",
    "description": "Q1r1c17: Immunomedics - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 mont",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q1",
    "context": ""
  },
  {
    "column": "Q13r1c1",
    "description": "Q13r1c1: Commercial Insurance (i.e. HMO/PPO) - We have just one final question for classification purposes. What is the distribution of your oncology patients at your primary practice setting/organization by insurance type?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q13",
    "context": ""
  },
  {
    "column": "Q13r2c1",
    "description": "Q13r2c1: Medicare - We have just one final question for classification purposes. What is the distribution of your oncology patients at your primary practice setting/organization by insurance type?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q13",
    "context": ""
  },
  {
    "column": "Q13r3c1",
    "description": "Q13r3c1: Medicaid - We have just one final question for classification purposes. What is the distribution of your oncology patients at your primary practice setting/organization by insurance type?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q13",
    "context": ""
  },
  {
    "column": "Q13r4c1",
    "description": "Q13r4c1: VA/DoD - We have just one final question for classification purposes. What is the distribution of your oncology patients at your primary practice setting/organization by insurance type?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q13",
    "context": ""
  },
  {
    "column": "Q13r5c1",
    "description": "Q13r5c1: Uninsured - We have just one final question for classification purposes. What is the distribution of your oncology patients at your primary practice setting/organization by insurance type?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q13",
    "context": ""
  },
  {
    "column": "Q13r6c1",
    "description": "Q13r6c1: Other - We have just one final question for classification purposes. What is the distribution of your oncology patients at your primary practice setting/organization by insurance type?",
    "level": "sub",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "Q13",
    "context": ""
  },
  {
    "column": "Prostate_Master_for_Programming_xlsx_tier",
    "description": "Prostate_Master_for_Programming_xlsx_tier: tier",
    "level": "parent",
    "valueType": "",
    "answerOptions": "NA",
    "parentQuestion": "NA",
    "context": ""
  }
]